Atara Biotherapeutics (ATRA)
(Delayed Data from NSDQ)
$8.31 USD
-0.28 (-3.26%)
Updated Sep 11, 2024 04:00 PM ET
After-Market: $8.30 -0.01 (-0.12%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth A Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/06/2024
Time: -- |
9/2024 | $-3.77 | 0.00% |
Earnings Summary
For their last quarter, Atara Biotherapeutics (ATRA) reported earnings of -$3.10 per share, missing the Zacks Consensus Estimate of -$1.25 per share. This reflects a negative earnings surprise of 148.00%. Look out for ATRA's next earnings release expected on November 06, 2024. For the next earning release, we expect the company to report earnings of -$3.77 per share, reflecting a year-over-year increase of 77.15%.
Earnings History
Price & Consensus
Zacks News for ATRA
Spruce Biosciences, Inc. (SPRB) Reports Q2 Loss, Tops Revenue Estimates
ATRA: What are Zacks experts saying now?
Zacks Private Portfolio Services